HEADER APOPTOSIS REGULATOR/INHIBITOR 16-AUG-13 4MAN TITLE BCL_2-NAVITOCLAX ANALOG (WITH INDOLE) COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-34, 92-207; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS 8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.H.PARK REVDAT 4 28-FEB-24 4MAN 1 REMARK SEQADV REVDAT 3 15-NOV-17 4MAN 1 REMARK REVDAT 2 02-AUG-17 4MAN 1 SOURCE REMARK REVDAT 1 29-JAN-14 4MAN 0 SPRSDE 29-JAN-14 4MAN 4LXE JRNL AUTH A.J.SOUERS,J.D.LEVERSON,E.R.BOGHAERT,S.L.ACKLER,N.D.CATRON, JRNL AUTH 2 J.CHEN,B.D.DAYTON,H.DING,S.H.ENSCHEDE,W.J.FAIRBROTHER, JRNL AUTH 3 D.C.HUANG,S.G.HYMOWITZ,S.JIN,S.L.KHAW,P.J.KOVAR,L.T.LAM, JRNL AUTH 4 J.LEE,H.L.MAECKER,K.C.MARSH,K.D.MASON,M.J.MITTEN,P.M.NIMMER, JRNL AUTH 5 A.OLEKSIJEW,C.H.PARK,C.M.PARK,D.C.PHILLIPS,A.W.ROBERTS, JRNL AUTH 6 D.SAMPATH,J.F.SEYMOUR,M.L.SMITH,G.M.SULLIVAN,S.K.TAHIR, JRNL AUTH 7 C.TSE,M.D.WENDT,Y.XIAO,J.C.XUE,H.ZHANG,R.A.HUMERICKHOUSE, JRNL AUTH 8 S.H.ROSENBERG,S.W.ELMORE JRNL TITL ABT-199, A POTENT AND SELECTIVE BCL-2 INHIBITOR, ACHIEVES JRNL TITL 2 ANTITUMOR ACTIVITY WHILE SPARING PLATELETS. JRNL REF NAT.MED. (N.Y.) V. 19 202 2013 JRNL REFN ISSN 1078-8956 JRNL PMID 23291630 JRNL DOI 10.1038/NM.3048 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 30912 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1561 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.14 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2829 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2362 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2672 REMARK 3 BIN R VALUE (WORKING SET) : 0.2362 REMARK 3 BIN FREE R VALUE : 0.2351 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.55 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2266 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.00600 REMARK 3 B22 (A**2) : -4.00600 REMARK 3 B33 (A**2) : 8.01210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.267 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.160 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2509 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3425 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 840 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 58 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 416 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2509 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 272 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3055 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.63 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.67 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MAN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081676. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30912 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 18.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M LI2SO4, 0.1 M TRIS HCL, PH 8.5, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.74600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 76.11900 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 25.37300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 HIS A 1 REMARK 465 ALA A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 THR A 5 REMARK 465 TRP A 28 REMARK 465 ASP A 29 REMARK 465 ALA A 30 REMARK 465 GLY A 31 REMARK 465 ASP A 32 REMARK 465 ASP A 73 REMARK 465 VAL A 74 REMARK 465 GLU A 75 REMARK 465 GLU A 76 REMARK 465 ASN A 77 REMARK 465 ARG A 78 REMARK 465 THR A 79 REMARK 465 GLU A 80 REMARK 465 ALA A 81 REMARK 465 PRO A 82 REMARK 465 GLU A 83 REMARK 465 GLY A 84 REMARK 465 THR A 85 REMARK 465 GLU A 86 REMARK 465 SER A 87 REMARK 465 SER A 202 REMARK 465 MET A 203 REMARK 465 ARG A 204 REMARK 465 MET B -1 REMARK 465 ALA B 0 REMARK 465 HIS B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 THR B 5 REMARK 465 TRP B 28 REMARK 465 ASP B 29 REMARK 465 ALA B 30 REMARK 465 GLY B 31 REMARK 465 ASP B 32 REMARK 465 ASP B 73 REMARK 465 VAL B 74 REMARK 465 GLU B 75 REMARK 465 GLU B 76 REMARK 465 ASN B 77 REMARK 465 ARG B 78 REMARK 465 THR B 79 REMARK 465 GLU B 80 REMARK 465 ALA B 81 REMARK 465 PRO B 82 REMARK 465 GLU B 83 REMARK 465 GLY B 84 REMARK 465 THR B 85 REMARK 465 GLU B 86 REMARK 465 SER B 87 REMARK 465 SER B 202 REMARK 465 MET B 203 REMARK 465 ARG B 204 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 7 -119.39 -68.78 REMARK 500 TYR B 7 -139.28 -175.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Y1 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Y1 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4LVT RELATED DB: PDB REMARK 900 RELATED ID: 4LXD RELATED DB: PDB DBREF 4MAN A -1 32 UNP P10415 BCL2_HUMAN 1 34 DBREF 4MAN A 89 204 UNP P10415 BCL2_HUMAN 92 207 DBREF 4MAN B -1 32 UNP P10415 BCL2_HUMAN 1 34 DBREF 4MAN B 89 204 UNP P10415 BCL2_HUMAN 92 207 SEQADV 4MAN ASP A 73 UNP P10415 LINKER SEQADV 4MAN VAL A 74 UNP P10415 LINKER SEQADV 4MAN GLU A 75 UNP P10415 LINKER SEQADV 4MAN GLU A 76 UNP P10415 LINKER SEQADV 4MAN ASN A 77 UNP P10415 LINKER SEQADV 4MAN ARG A 78 UNP P10415 LINKER SEQADV 4MAN THR A 79 UNP P10415 LINKER SEQADV 4MAN GLU A 80 UNP P10415 LINKER SEQADV 4MAN ALA A 81 UNP P10415 LINKER SEQADV 4MAN PRO A 82 UNP P10415 LINKER SEQADV 4MAN GLU A 83 UNP P10415 LINKER SEQADV 4MAN GLY A 84 UNP P10415 LINKER SEQADV 4MAN THR A 85 UNP P10415 LINKER SEQADV 4MAN GLU A 86 UNP P10415 LINKER SEQADV 4MAN SER A 87 UNP P10415 LINKER SEQADV 4MAN GLU A 88 UNP P10415 LINKER SEQADV 4MAN ASP B 73 UNP P10415 LINKER SEQADV 4MAN VAL B 74 UNP P10415 LINKER SEQADV 4MAN GLU B 75 UNP P10415 LINKER SEQADV 4MAN GLU B 76 UNP P10415 LINKER SEQADV 4MAN ASN B 77 UNP P10415 LINKER SEQADV 4MAN ARG B 78 UNP P10415 LINKER SEQADV 4MAN THR B 79 UNP P10415 LINKER SEQADV 4MAN GLU B 80 UNP P10415 LINKER SEQADV 4MAN ALA B 81 UNP P10415 LINKER SEQADV 4MAN PRO B 82 UNP P10415 LINKER SEQADV 4MAN GLU B 83 UNP P10415 LINKER SEQADV 4MAN GLY B 84 UNP P10415 LINKER SEQADV 4MAN THR B 85 UNP P10415 LINKER SEQADV 4MAN GLU B 86 UNP P10415 LINKER SEQADV 4MAN SER B 87 UNP P10415 LINKER SEQADV 4MAN GLU B 88 UNP P10415 LINKER SEQRES 1 A 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 B 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 B 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 B 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 B 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 B 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 B 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 B 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 B 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 B 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 B 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 B 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 B 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 B 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG HET 1Y1 A 301 84 HET 1Y1 B 301 85 HETNAM 1Y1 4-[4-({4'-CHLORO-3-[2-(DIMETHYLAMINO)ETHOXY]BIPHENYL-2- HETNAM 2 1Y1 YL}METHYL)PIPERAZIN-1-YL]-2-(1H-INDOL-5-YLOXY)-N-({3- HETNAM 3 1Y1 NITRO-4-[(TETRAHYDRO-2H-PYRAN-4-YLMETHYL) HETNAM 4 1Y1 AMINO]PHENYL}SULFONYL)BENZAMIDE FORMUL 3 1Y1 2(C48 H52 CL N7 O8 S) FORMUL 5 HOH *260(H2 O) HELIX 1 1 ASP A 8 ARG A 24 1 17 HELIX 2 2 VAL A 89 TYR A 105 1 17 HELIX 3 3 TYR A 105 SER A 114 1 10 HELIX 4 4 THR A 122 PHE A 135 1 14 HELIX 5 5 ASN A 140 ARG A 161 1 22 HELIX 6 6 PRO A 165 LEU A 182 1 18 HELIX 7 7 LEU A 182 ASN A 189 1 8 HELIX 8 8 GLY A 190 GLY A 200 1 11 HELIX 9 9 ASP B 8 ARG B 24 1 17 HELIX 10 10 VAL B 89 TYR B 105 1 17 HELIX 11 11 TYR B 105 SER B 114 1 10 HELIX 12 12 THR B 122 ARG B 136 1 15 HELIX 13 13 ASN B 140 ARG B 161 1 22 HELIX 14 14 PRO B 165 LEU B 182 1 18 HELIX 15 15 LEU B 182 ASN B 189 1 8 HELIX 16 16 GLY B 190 GLY B 200 1 11 SITE 1 AC1 21 ALA A 97 ASP A 100 PHE A 101 TYR A 105 SITE 2 AC1 21 ASP A 108 PHE A 109 MET A 112 LEU A 134 SITE 3 AC1 21 TRP A 141 GLY A 142 ARG A 143 ALA A 146 SITE 4 AC1 21 ASN A 160 GLU A 162 SER A 164 PRO A 165 SITE 5 AC1 21 TYR A 199 HOH A 406 HOH A 519 HOH A 521 SITE 6 AC1 21 HOH A 531 SITE 1 AC2 20 HOH A 501 ALA B 97 ASP B 100 PHE B 101 SITE 2 AC2 20 TYR B 105 ASP B 108 PHE B 109 MET B 112 SITE 3 AC2 20 LEU B 134 TRP B 141 GLY B 142 ARG B 143 SITE 4 AC2 20 ALA B 146 GLU B 162 SER B 164 PRO B 165 SITE 5 AC2 20 TYR B 199 HOH B 406 HOH B 518 HOH B 524 CRYST1 71.375 71.375 101.492 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014011 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014011 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009853 0.00000